Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

DOI Web Site Web Site 1 Citations

Journal

  • The Lancet

    The Lancet 397 (10279), 1063-1074, 2021-03

    Elsevier BV

Citations (1)*help

See more

Report a problem

Back to top